Your browser doesn't support javascript.
loading
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria.
Suliman, Sara; Murphy, Melissa; Musvosvi, Munyaradzi; Gela, Anele; Meermeier, Erin W; Geldenhuys, Hennie; Hopley, Christiaan; Toefy, Asma; Bilek, Nicole; Veldsman, Ashley; Hanekom, Willem A; Johnson, John L; Boom, W Henry; Obermoser, Gerlinde; Huang, Huang; Hatherill, Mark; Lewinsohn, David M; Nemes, Elisa; Scriba, Thomas J.
Afiliação
  • Suliman S; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa; ssuliman1@bwh.harvard.edu.
  • Murphy M; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.
  • Musvosvi M; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
  • Gela A; Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Meermeier EW; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.
  • Geldenhuys H; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.
  • Hopley C; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
  • Toefy A; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.
  • Bilek N; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.
  • Veldsman A; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
  • Hanekom WA; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.
  • Johnson JL; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.
  • Boom WH; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
  • Obermoser G; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR 97239.
  • Huang H; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.
  • Hatherill M; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.
  • Lewinsohn DM; Division of Immunology, Department of Pathology, University of Cape Town, Cape Town 7925, South Africa.
  • Nemes E; South African Tuberculosis Vaccine Initiative, University of Cape Town, Cape Town 7925, South Africa.
  • Scriba TJ; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.
J Immunol ; 203(11): 2917-2927, 2019 12 01.
Article em En | MEDLINE | ID: mdl-31611259
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Antígenos de Histocompatibilidade Menor / Células T Invariantes Associadas à Mucosa / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Antígenos de Histocompatibilidade Menor / Células T Invariantes Associadas à Mucosa / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article